Rajen Mody
Children's Oncology Group · University of Michigan Rogel Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rajen Mody as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:44 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03526250 · Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI) · completed · Advanced Malignant Solid Neoplasm, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma · principal investigator
- Ph2NCT01767194 · Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed NeuroblastomaNational Cancer Institute (NCI) · completed · Ganglioneuroblastoma, Recurrent Neuroblastoma · principal investigator
- Ph1NCT00644696 · Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaUniversity of Michigan Rogel Cancer Center · completed · Neuroblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- COG NCTN Network Group Operations CenterU10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026Named on NCT03526250, NCT01767194
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT01767194
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ependymoma.